Literature DB >> 232029

Effect of captopril on renal vascular tone in patients with essential hypertension.

A Mimran, H R Brunner, G A Turini, B Waeber, D Brunner.   

Abstract

1. The effect of acute inhibition of angiotensin-converting enzyme by captopril (50 mg) on renal haemodynamics and function was assessed in nine patients with essential hypertension on unrestricted sodium intake (n = 8) or low sodium diet (n = 1). 2. Captopril induced a rapid and significant decrease in arterial pressure, which was maximal within 60 min. 3. Effective renal plasma flow (ERPF) increased, glomerular filtration rate (GFR) did not change and filtration fraction (FF) decreased after captopril. No change in sodium excretion and a decrease in urinary potassium occurred. 4. In the patient on low sodium diet, captopril induced striking increases in GFR and ERPF (64 and 106% respectively). 5. The logarithm of baseline plasma renin activity was positvely correlated with the change in ERPF and negatively correlated with changes in FF and renal resistance. 6. The results indicate that in patients with essential hypertension angiotensin participates actively in the maintenance of renal vascular tone at the efferent arteriolar level. A possible influence of kinins remains to be defined.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 232029     DOI: 10.1042/cs057421s

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

Review 1.  Perindopril. A review of its pharmacokinetics and clinical pharmacology.

Authors:  R J Macfadyen; K R Lees; J L Reid
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 2.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 3.  Non-steroidal anti-inflammatory drugs and angiotensin converting enzyme inhibitors: a commonly prescribed combination with variable effects on renal function.

Authors:  N D Sturrock; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

4.  Long-term effects of captopril on renal function in hypertensive patients.

Authors:  Z Glück; C Beretta-Piccoli; F C Reubi
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 5.  Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

Review 6.  Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

7.  Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function.

Authors:  K Boehringer; P Weidmann; L Link; M G Bianchetti; H Schiffl; F C Reubi
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

8.  Hypertensive crisis treated with orally administered captopril.

Authors:  J Biollaz; B Waeber; H R Brunner
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  The effects of cilazapril alone and in combination with frusemide in healthy subjects.

Authors:  G D Johnston; A P Passmore
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.